Showing results (51-60 of 117) with videos related to
Sort By:
Pageof 12
Virchows Archiv : an International Journal of Pathology|August 3, 2018
MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort studySimon Andreasen, Qihua Tan, Tina Klitmøller Agander, et al.Human Mutation|July 30, 2013
Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelinesLogan C Walker, Phillip J Whiley, Claude Houdayer, et al.Breast Cancer Research and Treatment|December 25, 2010
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicingMads Thomassen, Inge Søkilde Pedersen, Ida Vogel, et al.Familial Cancer|August 22, 2009
Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patientsLise Lotte Christensen, Reetta Kariola, Mari K Korhonen, et al.Cancers|June 13, 2025
Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian CancerAnne K Munch, Elisabeth S Feldner, Caroline H Bækgaard, et al.Molecular Genetics & Genomic Medicine|November 15, 2024
Reclassification of Two MLH1 Variants of Uncertain Significance Utilizing Clinical and Functional DataJane Hübertz Frederiksen, Ulf Birkedal, Sarah Bachmann, et al.Molecular and Cellular Endocrinology|March 28, 2006
Characteristics of the Danish families with multiple endocrine neoplasia type 1Anne Charlotte Jäger, Lennart Friis-Hansen, Thomas V O Hansen, et al.Human Mutation|July 4, 2012
A guide for functional analysis of BRCA1 variants of uncertain significanceGaël A Millot, Marcelo A Carvalho, Sandrine M Caputo, et al.Plos One|March 25, 2015
Molecular characterization of melanoma cases in Denmark suspected of genetic predispositionKarin A W Wadt, Lauren G Aoude, Lotte Krogh, et al.Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.Pageof 12